A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHA
Public ClinicalTrials.gov record NCT03764618. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
Study identification
- NCT ID
- NCT03764618
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Rigel Pharmaceuticals
- Industry
- Enrollment
- 90 participants
Conditions and interventions
Conditions
Interventions
- Fostamatinib disodium Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 100 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 23, 2019
- Primary completion
- Apr 10, 2022
- Completion
- Apr 10, 2022
- Last update posted
- May 24, 2023
2019 – 2022
United States locations
- U.S. sites
- 26
- U.S. states
- 17
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner MD Anderson Cancer Center | Gilbert | Arizona | 85234 | — |
| Mayo Clinic Hospital | Phoenix | Arizona | 85054 | — |
| Arizona Oncology Associates, PC--HOPE Division | Tucson | Arizona | 85711 | — |
| Moores UC San Diego Cancer Center | La Jolla | California | 92037 | — |
| University of Southern California | Los Angeles | California | 90033 | — |
| Harbor UCLA - Lundquist Institute | Torrance | California | 90502 | — |
| The Oncology Institute of Hope and Innovation | Whittier | California | 90603 | — |
| Banner MD Anderson Cancer Center at North Colorado Medical Center | Greeley | Colorado | 80538 | — |
| Georgetown University - Lombardi Comprehensive Cancer Center | Washington D.C. | District of Columbia | 20007 | — |
| Cancer Specialists of North Florida | Jacksonville | Florida | 32256 | — |
| Piedmont Cancer Institute | Atlanta | Georgia | 30318 | — |
| Affiliated Oncologists | Chicago Ridge | Illinois | 60415 | — |
| John Hopkins Bayview Medical Center | Baltimore | Maryland | 21205 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Comprehensive Cancer Centers of Nevada | Las Vegas | Nevada | 89169 | — |
| Rutgers - Robert Wood Johnson Medical School | New Brunswick | New Jersey | 08901 | — |
| Montefiore Medical Center | The Bronx | New York | 10461 | — |
| Duke Cancer Network | Clayton | North Carolina | 27520 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Texas Oncology - Baylor Research Institute | Dallas | Texas | 75246 | — |
| Clear Lake Specialties, Research Dept. | Webster | Texas | 77598 | — |
| American Oncology Network Vista Oncology Division | Olympia | Washington | 98506 | — |
| Swedish Cancer Institute | Seattle | Washington | 98104 | — |
| University of Washington | Seattle | Washington | 98109 | — |
| Versiti Wisconsin, Inc. | Milwaukee | Wisconsin | 53226 | — |
| Marshfield Clinic Cancer Center - Stevens Point | Stevens Point | Wisconsin | 54482 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 76 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03764618, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 24, 2023 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03764618 live on ClinicalTrials.gov.